RenovoRx Inc
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
RNXT$1.180.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit)
(in thousands, except share amounts)
| Convertible Preferred Stock · Common Stock · Additional Paid-In · Accumulated Other Comprehensive · Accumulated · Total Stockholders’ Equity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Capital · Income · Deficit · (Deficit) | ||||||||||
| Balance—December 31, 2021 | - | $ | - | 8,933,989 | $1 | $36,632 | $ | - | $(21,284) | $15,349 |
| Issuance of common stock upon exercise of stock options | - | - | 160,212 | - | 42 | - | - | 42 | ||
| Issuance of restricted stock awards | - | - | 3,500 | - | 14 | - | - | 14 | ||
| Stock-based compensation expense | - | - | - | - | 630 | - | - | 630 | ||
| Other comprehensive income | - | - | - | - | - | 17 | - | 17 | ||
| Net loss | - | - | - | - | - | - | (9,889) | (9,889) | ||
| Balance—December 31, 2022 | - | - | 9,097,701 | 1 | 37,318 | 17 | (31,173) | 6,163 | ||
| Issuance of common stock upon exercise of stock options | - | - | 8,247 | - | 8 | - | - | 8 | ||
| Issuance of restricted stock awards | - | - | 30,000 | - | - | - | - | - | ||
| Issuance of common stock upon the registered direct offering | - | - | 1,000,000 | - | - | - | - | - | ||
| Issuance and exercise of common stock warrants upon the registered direct offering | - | - | 557,632 | - | - | - | - | - | ||
| Stock-based compensation expense | - | - | - | - | 1,078 | - | - | 1,078 | ||
| Other comprehensive income | - | - | - | - | - | (17) | - | (17) | ||
| Net loss | - | - | - | - | - | - | (10,232) | (10,232) | ||
| Balance—December 31, 2023 | - | $ | - | 10,693,580 | $1 | $38,404 | $ | - | $(41,405) | $(3,000) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.